ARK Genomics Fund Poised for the Future of Healthcare

There are some investment niches where active management can benefit investors and biotechnology. Genomics is one such industry and the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) stands out as a prime example. Genomic funds are some of the shining stars in the collection of stellar...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.